duloxetine hydrochloride has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Park, SY; Zinnah, KMA | 1 |
Gül, HL; Gül, ŞK; Tepetam, H | 1 |
Hao, A; Hideyama, T; Sato, T; Shibuya, H; Shiio, Y; Tsujimoto, Y | 1 |
1 trial(s) available for duloxetine hydrochloride and Lung Neoplasms
Article | Year |
---|---|
Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Cancer Pain; Duloxetine Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Prospective Studies; Quality of Life; Treatment Outcome | 2020 |
2 other study(ies) available for duloxetine hydrochloride and Lung Neoplasms
Article | Year |
---|---|
Duloxetine Enhances TRAIL-mediated Apoptosis
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagic Cell Death; Cell Line, Tumor; Cell Survival; Duloxetine Hydrochloride; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Microtubule-Associated Proteins; Phosphorylation; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA-Binding Proteins; RNA, Small Interfering; Serotonin and Noradrenaline Reuptake Inhibitors; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2019 |
[Anti-Hu antibody positive sensory neuronopathy causing painful legs and moving toes (PLMT) in a 75-year-old female with small cell lung cancer (SCLC)].
Topics: Aged; Antineoplastic Agents; Ataxia; Autoantibodies; Duloxetine Hydrochloride; ELAV Proteins; Female; Humans; Immunoglobulins, Intravenous; Leg; Lung Neoplasms; Movement Disorders; Pain; Paraneoplastic Polyneuropathy; Paraneoplastic Syndromes; Paresthesia; Small Cell Lung Carcinoma; Toes | 2018 |